Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Endocrinol ; 29(4): 361-4, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23305451

ABSTRACT

OBJECTIVE: Sex hormone binding globulin (SHBG) levels are often low in women with polycystic ovary syndrome (PCOS). In addition to metabolic and nutritional factors, SHBG levels are determined by genetic polymorphisms in SHBG gene. The aim of this study was to investigate the association of polymorphisms in exon 8 of SHBG gene with anthropometric and biochemical features of women with PCOS. DESIGN: Prospective, observational study. PATIENTS: One hundred and ninety-four women with PCOS. MAIN OUTCOME MEASURE(S): Genotype analysis of exon 8 in SHBG gene was performed. Serum SHBG, total testosterone, free testosterone, 17-α-hydroxyprogesterone, TSH, PRL, glucose and insulin levels were determined. MAIN FINDING(S): Single nucleotide polymorphism (SNP) E326K located at codon 326 in exon 8 of SHBG gene was identified. Serum SHBG levels decreased significantly with increasing copy number of the variant allele for SNP E326K after adjustment for BMI, androgenic and insulin-related traits. Genotype analysis also revealed SNP, rs6259, located at codon 327 in exon 8 of SHBG gene, which is not associated with SHBG levels. CONCLUSION: SNP, E326K, in exon 8 of SHBG gene may influence the metabolism of SHBG independently of BMI, androgenic and insulin-related features in women with PCOS.


Subject(s)
Exons , Insulin Resistance/genetics , Polycystic Ovary Syndrome/genetics , Polymorphism, Single Nucleotide , Sex Hormone-Binding Globulin/genetics , Adult , Alleles , Blood Glucose , Body Mass Index , Female , Gene Frequency , Genotype , Humans , Insulin/blood , Polycystic Ovary Syndrome/blood , Prolactin/blood , Prospective Studies , Sex Hormone-Binding Globulin/metabolism , Testosterone/blood , Thyrotropin/blood
2.
Fertil Steril ; 77(3): 526-8, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11872207

ABSTRACT

OBJECTIVE: To investigate the effect of an angiotensin-converting enzyme inhibitor, lisinopril, on serum androgen and sex-hormone-binding globulin (SHBG) levels in hypertensive women with polycystic ovary syndrome (PCOS). DESIGN: Prospective, observational study. SETTING: Infertility Clinic of the Sani Konukoglu Hospital, Gaziantep, Turkey. PATIENT(S): Ten hypertensive women with PCOS. INTERVENTION(S): Lisinopril, 10 mg/day, for 4 weeks. MAIN OUTCOME MEASURE(S)): Serum levels of gonadotropins, DHEAS, total T, free T, 17 alpha-hydroxyprogesterone (17-OHP), androstenedione, E2, SHBG, TSH, and PRL were determined. RESULT(S): Hypertension treatment with lisinopril (10 mg/day for 4 weeks) resulted in a statistically significant decrease in serum free T levels. However, there was no difference in the SHBG levels. CONCLUSION(S): Use of lisinopril, an angiotensin-converting enzyme inhibitor, results in decreased free T levels independently of SHBG. It may affect the free T levels by affecting the ovarian renin-angiotensin system.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Hyperandrogenism/blood , Hypertension/blood , Lisinopril/pharmacology , Polycystic Ovary Syndrome/blood , Progesterone/analogs & derivatives , Adult , Androstenedione/blood , Dehydroepiandrosterone Sulfate/blood , Estradiol/blood , Female , Gonadotropins/blood , Humans , Hyperandrogenism/drug therapy , Hypertension/complications , Hypertension/drug therapy , Polycystic Ovary Syndrome/complications , Progesterone/blood , Prolactin/blood , Prospective Studies , Sex Hormone-Binding Globulin/metabolism , Testosterone/blood , Thyrotropin/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...